Gynecological and Dermatological Aspects of Diagnostics of Polycystic Ovary Syndrome from Puberty to Menopause
September 2023
in “
Reproductive health of woman
”
TLDR PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.
The document reviews the gynecological and dermatological aspects of diagnosing polycystic ovary syndrome (PCOS) from puberty to menopause, emphasizing its prevalence and impact on women's health. PCOS is linked to over half of endocrine infertility cases and affects 20-22% of infertile marriages. It increases risks for gestational diabetes and hypertensive disorders during pregnancy. Hyperandrogenism, a key feature, is associated with symptoms like hirsutism, acne, and androgenetic alopecia, with hair loss linked to metabolic syndrome and cardiovascular risks. The modified Rotterdam criteria are recommended for diagnosis, focusing on hyperandrogenism, oligoanovulation, and polycystic ovarian morphology. The document highlights the need for comprehensive evaluation and personalized treatment plans to manage symptoms and reduce long-term health risks.